MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration

Cebrián, Carolina, Zucca, Fabio A., Mauri, Pierluigi, Steinbeck, Julius A., Studer, Lorenz, Scherzer, Clemens R., Kanter, Ellen, Budhu, Sadna +5 more·2014·Nature Communications

Cited by (337)

Items 101–200 of 337

  1. Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration
    Ramona Miske, Catharina C. Groß, Madeleine Scharf, Kristin S. Golombeck, Marvin Hartwig, Urvashi Bhatia, Andreas Schulte‐Mecklenbeck, Kathrin Bönte, Christine Strippel, Ludger J. Schöls et al. · 2016 · Neurology Neuroimmunology & Neuroinflammation
  2. Elucidating Pro-Inflammatory Cytokine Responses after Traumatic Brain Injury in a Human Stem Cell Model
    Eric Peter Thelin, Claire E. Hall, Kunal Gupta, Keri L.H. Carpenter, Siddharthan Chandran, Peter J. Hutchinson, Rickie Patani, Adel E Helmy · 2017 · Journal of Neurotrauma
  3. Mycobacterium tuberculosis infection of the ‘non‐classical immune cell’
    Philippa J. Randall, Nai‐Jen Hsu, Valerie F. J. Quesniaux, Bernhard Ryffel, Muazzam Jacobs · 2015 · Immunology and Cell Biology
  4. MHC-I promotes apoptosis of GABAergic interneurons in the spinal dorsal horn and contributes to cancer induced bone pain
    Qiaochu Fu, Dai Shi, Ya‐Qun Zhou, Hua Zheng, Hong‐Bing Xiang, Xuebi Tian, Feng Gao, Anne Manyande, Fei Cao, Yuke Tian et al. · 2016 · Experimental Neurology
  5. Advances and challenges: dendritic cell vaccination strategies for glioblastoma
    Teilo H. Schaller, John Howard Sampson · 2016 · Expert Review of Vaccines
  6. Stress increases MHC-I expression in dopaminergic neurons and induces autoimmune activation in Parkinson's disease
    Baoyan Wang, Yongyi Ye, Chen Qian, Hongbo Zhang, Hengxu Mao, Longping Yao, Xiang Sun, Guohui Lu, Shizhong Zhang · 2021 · Neural Regeneration Research
  7. Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α‐synuclein, amyloid‐β and insulin resistance in neurodegenerative diseases
    Ian A. Clark, Bryce Vissel · 2018 · British Journal of Pharmacology
  8. Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans
    Samuel E. Brennan, Matthew Keon, Bing Liu, Zheng Su, Nitin K. Saksena · 2019 · Molecular Neurobiology
  9. Parkinson's disease is an autoimmune disease: A reappraisal
    Srinivasa Reddy Bonam, Sylviane Muller · 2020 · Autoimmunity Reviews
  10. Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis
    Fiona Limanaqi, Carla Letizia Busceti, Francesca Biagioni, Gloria Lazzeri, Maurizio Forte, Sonia Schiavon, Sebastiano Sciarretta, Giacomo Frati, Francesco Fornai · 2020 · Antioxidants
  11. Toward curing neurological autoimmune disorders: Biomarkers, immunological mechanisms, and therapeutic targets
    Yahel Segal‬‏, John N. Soltys, Benjamin D. S. Clarkson, Charles L. Howe, Sarosh R. Irani, Sean Joseph Pittock · 2025 · Neuron
  12. Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders
    Scott E. Ugras, Malcolm J. Daniels, Hossein Fazelinia, Neal S. Gould, Anastasia K. Yocum, Kelvin C. Luk, Esteban Luna, Hua Ding, Chris G. McKennan, Steven H. Seeholzer et al. · 2018 · EBioMedicine
  13. Regulation of immune-driven pathogenesis in Parkinson’s disease by gut microbiota
    Wenxia Zheng, Rongni He, Zhenxing Yan, Yaowei Huang, Wei Huang, Zhuoyi Cai, Yuying Su, Siqin Liu, Yiting Deng, Qing Wang et al. · 2020 · Brain Behavior and Immunity
  14. Age-Related Midbrain Inflammation and Senescence in Parkinson’s Disease
    Taylor Russo, Markus Rießland · 2022 · Frontiers in Aging Neuroscience
  15. Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models
    Capucciati, Andrea, Zucca, Fabio A., Monzani, Enrico, Zecca, Luigi, Casella, Luigi, Hofer, Tim · 2021 · Antioxidants
  16. T cells, α-synuclein and Parkinson disease
    Francesca Garretti, Connor Monahan, Alessandro Sette, Dritan Agalliu, David Sulzer · 2022 · Handbook of clinical neurology
  17. The impact of α-synuclein aggregates on blood-brain barrier integrity in the presence of neurovascular unit cells
    Hamdam Hourfar, Farhang Aliakbari, Shabboo Rahimi Aqdam, Zahra Nayeri, Hassan Bardania, Daniel E. Otzen, Dina Morshedi · 2022 · International Journal of Biological Macromolecules
  18. Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson's disease in mice
    Gejuan Zhang, Geqiang Yang, Jian Liu · 2019 · Life Sciences
  19. Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson’s Disease
    Songzhe He, Shan Zhong, Gang Liu, Jun Yang · 2020 · Neurodegenerative Diseases
  20. Pseudoloma neurophilia : A Retrospective and Descriptive Study of Nervous System and Muscle Infections, with New Implications for Pathogenesis and Behavioral Phenotypes
    Sean Spagnoli, Lan Xue, Katrina N. Murray, Fidelis Chow, Michael L. Kent · 2015 · Zebrafish
  21. Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction
    Andrea Mancini, Veronica Ghiglieri, Lucilla Parnetti, Paolo Calabresi, Massimiliano Di Filippo · 2021 · Frontiers in Immunology
  22. Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
    Sheila K. Pirooznia, Liana S. Rosenthal, Valina Lynn Dawson, Ted M. Dawson · 2021 · Pharmacological Reviews
  23. Impact of sex on neuroimmune contributions to Parkinson’s disease
    Mélanie Bourque, Marc Morissette, Denis Soulet, Thérèse Di Paolo · 2023 · Brain Research Bulletin
  24. The Appendix in Parkinson’s Disease: From Vestigial Remnant to Vital Organ?
    Bryan A. Killinger, Viviane Labrie · 2019 · Journal of Parkinson s Disease
  25. Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease
    Talia Krainc, Mariana H.G. Monje, Morgan Kinsinger, Bernabé I. Bustos, Steven J Lubbe · 2022 · Movement Disorders
  26. Chronic Infiltration of T Lymphocytes into the Brain in a Non-human Primate Model of Parkinson’s Disease
    Jincheol Seo, Junghyung Park, Keonwoo Kim, Jinyoung Won, Hyeon-Gu Yeo, Yeung Bae Jin, Bon‐Sang Koo, Kyung Seob Lim, Kang-Jin Jeong, Philyong Kang et al. · 2020 · Neuroscience
  27. Mitophagy in Parkinson's disease: From pathogenesis to treatment target
    Francesco Dernie · 2020 · Neurochemistry International
  28. Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
    Gundersen, Vidar · 2021 · Frontiers in Neuroscience
  29. Neuronal Presentation of Antigen and Its Possible Role in Parkinson’s Disease
    Benjamin D. Hobson, David L. Sulzer · 2022 · Journal of Parkinson s Disease
  30. Riddles in the dark: Decoding the relationship between neuromelanin and neurodegeneration in locus coeruleus neurons
    Alexa F. Iannitelli, David Weinshenker · 2023 · Neuroscience & Biobehavioral Reviews
  31. Specificity of Adaptive Immune Responses in Central Nervous System Health, Aging and Diseases
    Chiara Rickenbach, Christoph Gericke · 2022 · Frontiers in Neuroscience
  32. Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson’s Disease
    Murad Al‐Nusaif, Yushan Lin, Tianbai Li, Cheng Cheng, Weidong Le · 2022 · International Journal of Molecular Sciences
  33. The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications
    Katarzyna Z. Kuter, Maria Angela Cenci, Anna Rosa Carta · 2020 · Progress in brain research
  34. Microbes and Parkinson’s disease: from associations to mechanisms
    Tyler Cannon, Samantha Gruenheid · 2022 · Trends in Microbiology
  35. Antigen-specific age-related memory CD8 T cells induce and track Alzheimer’s-like neurodegeneration
    Akanksha Panwar, Altan Rentsendorj, Michelle Jhun, Robert M. Cohen, Ryan Cordner, Nicole Gull, Robert N. Pechnick, Gretchen Duvall, Armen Mardiros, David Golchian et al. · 2024 · Proceedings of the National Academy of Sciences
  36. Neurons and T cells: Understanding this interaction for inflammatory neurological diseases
    Lidia Yshii, Christina Gebauer, Raphaël Bernard‐Valnet, Roland Liblau · 2015 · European Journal of Immunology
  37. Hidden phenotypes of PINK1/Parkin knockout mice
    Swagatika Paul, Alicia M. Pickrell · 2021 · Biochimica et Biophysica Acta (BBA) - General Subjects
  38. Catecholamines and Parkinson’s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview
    Toshiharu Nagatsu · 2023 · Journal of Neural Transmission
  39. Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits
    Ariadna Laguna, Núria Peñuelas, Marta González-Sepúlveda, Alba Nicolau, Sébastien Arthaud, Camille Guillard-Sirieix, Marina Lorente Picón, Joan Compte, Lluís Miquel-Rio, Helena Xicoy et al. · 2024 · Nature Communications
  40. CD8+ T Cell-Mediated Neuronal Dysfunction and Degeneration in Limbic Encephalitis
    Petra Ehling, Nico Melzer, Thomas Budde, Sven Guenther Meuth · 2015 · Frontiers in Neurology
  41. Cell Clearing Systems Bridging Neuro-Immunity and Synaptic Plasticity
    Fiona Limanaqi, Francesca Biagioni, Carla Letizia Busceti, Larisa Ryskalin, Paola Soldani, Alessandro Frati, Francesco Fornai · 2019 · International Journal of Molecular Sciences
  42. Differential Neuroprotective and Anti-Inflammatory Effects of L-Type Voltage Dependent Calcium Channel and Ryanodine Receptor Antagonists in the Substantia Nigra and Locus Coeruleus
    Sarah C. Hopp, Sarah E Royer, Heather M. D’Angelo, Roxanne M. Kaercher, David A. Fisher, Gary L. Wenk · 2014 · Journal of Neuroimmune Pharmacology
  43. Pathology: The prion principle
    Simon J. Makin · 2016 · Nature
  44. Narcolepsy type 1: what have we learned from immunology?
    Birgitte Rahbek Kornum · 2020 · SLEEP
  45. Conserved and cell type-specific transcriptional responses to IFN-γ in the ventral midbrain
    Benjamin D. Hobson, Adrien T. Stanley, Mark B. De Los Santos, Bruce Culbertson, Eugene V. Mosharov, Peter A. Sims, David L. Sulzer · 2023 · Brain Behavior and Immunity
  46. Specific T-cell activation in peripheral blood and cerebrospinal fluid in central disorders of hypersomnolence
    Julian Lippert, Peter Young, Catharina C. Groß, Sven Guenther Meuth, Bianca Dräger, Anja Schirmacher, Anna Heidbreder · 2018 · SLEEP
  47. Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease
    Lu Wang, Yayun Yan, Liyao Zhang, Yan Liu, Ruirui Luo, Ying Chang · 2021 · Journal of Neural Transmission
  48. Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons
    Shijun Wang, Chun‐Hsien Chu, Mingri Guo, Lulu Jiang, Hui Nie, Wei Zhang, Belinda C. Wilson, Yang Li, Tessandra Stewart, Jau‐Shyong Hong et al. · 2016 · Journal of Neuroinflammation
  49. Glycosylation in neuroinflammation: mechanisms, implications, and therapeutic strategies for neurodegenerative diseases
    Shenglan Cheng, Bo Xiao, Zhaohui Luo · 2025 · Translational Neurodegeneration
  50. New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
    Jolene S.Y. Tan, Yinxia Chao, Olaf Rötzschke, Eng‐King Tan · 2020 · International Journal of Molecular Sciences
  51. Viral-induced neuroinflammation: Different mechanisms converging to similar exacerbated glial responses
    Brenda Rocamonde, Uzma Ayesha Hasan, Cyrille Mathieu, Hélène Dutartre · 2023 · Frontiers in Neuroscience
  52. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease
    Lisa Rauschenberger, Jennifer K. Behnke, Alexander Grotemeyer, Susanne Knörr, Jens Volkmann, Chi Wang Ip · 2022 · Neurobiology of Disease
  53. STMHCpan, an accurate Star-Transformer-based extensible framework for predicting MHC I allele binding peptides
    Zheng Ye, Shaohao Li, Xue Mi, Baoyi Shao, Zhu Dai, B. Ding, Song-Wei Feng, Bo Sun, Yang Shen, Zhong-Dang Xiao · 2023 · Briefings Bioinform.
  54. Combined immunotherapy with “anti-insulin resistance” therapy as a novel therapeutic strategy against neurodegenerative diseases
    Yoshiki Takamatsu, Gilbert J. Ho, Wakako Koike, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Jianshe Wei, Kazunari Sekiyama, Makoto Hashimoto · 2017 · npj Parkinson s Disease
  55. T cells and Parkinson's disease
    Rodney Lee Mosley, Howard Eliot Gendelman · 2017 · The Lancet Neurology
  56. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond
    Jenny Valentina Garmendia, Claudia Valentina De Sanctis, Viswanath Das, Narendran Annadurai, Marián Hajdúch, Juan Bautista De Sanctis · 2023 · Current Neuropharmacology
  57. Comparative analysis of neuroinflammatory pathways in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis: insights into similarities and distinctions
    Julia Doroszkiewicz, Izabela Winkel, Barbara Mroczko · 2025 · Frontiers in Neuroscience
  58. Impaired migratory phenotype of CD4+ T cells in Parkinson’s disease
    Dejan Mamula, Shervin Khosousi, Yachao He, Vesna Lazarevic, Per Svenningsson · 2022 · npj Parkinson s Disease
  59. Immunology of West Nile Virus Infection and the Role of Alpha-Synuclein as a Viral Restriction Factor
    Kelsey E. Lesteberg, John David Beckham · 2018 · Viral Immunology
  60. CD8+ T cells exacerbate AD-like symptoms in mouse model of amyloidosis
    Xin Wang, Britney Campbell, Monica Bodogai, Ross A. McDevitt, Anton Patrikeev, Fedor E. Gusev, Emeline Ragonnaud, Konda Kumaraswami, Sophie D. Shirenova, Karin Vardy et al. · 2024 · Brain Behavior and Immunity
  61. The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
    Lena F. Burbulla, Dimitri Krainc · 2019 · Neurobiology of Disease
  62. Neuroprotective approaches to halt Parkinson's disease progression
    Piyong Sola, Praveen Thaggikuppe Krishnamurthy, Mamta Kumari, Gowramma Byran, Hosahalli Veerabhadrappa Gangadharappa, Kusuma Kumari Garikapati · 2022 · Neurochemistry International
  63. Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions
    Anna C. Stoll, Christopher J. Kemp, Joseph R. Patterson, Jacob W. Howe, Kathy Steece‐Collier, Kelvin C. Luk, Caryl E. Sortwell, Matthew J. Benskey · 2024 · Neurobiology of Disease
  64. Mitochondrial antigen presentation: a mechanism linking Parkinson’s disease to autoimmunity
    Ahmed M. Fahmy, Jonathan Boulais, Michel Desjardins, Diana Matheoud · 2019 · Current Opinion in Immunology
  65. Reduction of the Nitro Group to Amine by Hydroiodic Acid to Synthesize o-Aminophenol Derivatives as Putative Degradative Markers of Neuromelanin
    Kazumasa Wakamatsu, Hitomi Tanaka, Keisuke Tabuchi, Makoto Ojika, Fabio Andrea Zucca, Luigi Zecca, Shosuke Ito · 2014 · Molecules
  66. Novel co-culture model of T cells and midbrain organoids for investigating neurodegeneration in Parkinson’s disease
    Elizaveta M. Gerasimova, Amke C. Beenen, Daniel V. Kachkin, Martin Regensburger, Sebastian Zundler, David B. Blumenthal, Gloria Lutzny‐Geier, Beate Winner, Iryna Prots · 2025 · npj Parkinson s Disease
  67. Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes
    Maximilian Wulf, Katalin Barkovits, Karin Schork, Martin Eisenacher, Peter Franz Riederer, Manfred Gerlach, Britta Eggers, Katrin Marcus · 2022 · Journal of Neural Transmission
  68. DNMT1 regulates expression of MHC class I in post-mitotic neurons
    Julie Ry Gustafsson, Georgia Katsioudi, Matilda Degn, Patrick Ejlerskov, Shohreh Issazadeh‐Navikas, Birgitte Rahbek Kornum · 2018 · Molecular Brain
  69. Immune system and new avenues in Parkinson’s disease research and treatment
    Ava Nasrolahi, Fatemeh Safari, Mehdi Farhoudi, Afra Khosravi, Fereshteh Farajdokht, Saiyad Bastaminejad, Siamak Sandoghchian Shotorbani, Javad Mahmoudi · 2019 · Reviews in the Neurosciences
  70. RETRACTED ARTICLE: Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depression
    Kenneth Wengler, Brandon K. Ashinoff, Elena Pueraro, Clifford Cassidy, Guillermo Horga, Bret R. Rutherford · 2020 · Neuropsychopharmacology · Retracted
  71. AMPK-dependent Parkin activation suppresses macrophage antigen presentation to promote tumor progression
    Xinyu Wang, Yiyi Li, Yan Li, Xiumei Wang, Hongrui Song, Yingzhao Wang, Chunliu Huang, Chengzhou Mao, Lixiang Wang, Cheng Zhong et al. · 2025 · Science Advances
  72. Immunoproteasome is up-regulated in rotenone-induced Parkinson’s disease rat model
    Congcong Sun, Guoyong Jia, Xingbang Wang, Yun Wang, Yiming Liu · 2020 · Neuroscience Letters
  73. The CSF in neurosarcoidosis contains consistent clonal expansion of CD8 T cells, but not CD4 T cells
    Michael Paley, Brandi Baker, Steven Richard Dunham, Nicole Linskey, Claudia Cantoni, Kenneth Lee, Lynn Marisa Hassman, Jennifer Poursine‐Laurent, Elisha D. O. Roberson, David B. Clifford et al. · 2022 · Journal of Neuroimmunology
  74. Strawberry notch homolog 2 regulates the response to interleukin-6 in the central nervous system
    Taylor E. Syme, Magdalena Grill, Emina Hayashida, Barney Viengkhou, Iain Leslie Campbell, Markus J. Hofer · 2022 · Journal of Neuroinflammation
  75. Escalating Bi-Directional Feedback Loops between Proinflammatory Microglia and Mitochondria in Ageing and Post-Diagnosis of Parkinson’s Disease
    Shane Michael Ravenhill, Andrew H. Evans, Sheila G. Crewther · 2023 · Antioxidants
  76. Low‐variance RNAs identify Parkinson's disease molecular signature in blood
    Maria D. Chikina, Christophe Gerald, Xianting Li, Yongchao Ge, Hanna Pinças, Venugopalan D. Nair, Aaron K. Wong, Arjun Krishnan, Olga G. Troyanskaya, Deborah Raymond et al. · 2015 · Movement Disorders
  77. Neuronal MHC Class I Expression Is Regulated by Activity Driven Calcium Signaling
    Dan Lv, Yuqing Shen, Yaqin Peng, Jiane Liu, Fengqin Miao, Jianqiong Zhang · 2015 · PLoS ONE
  78. Non-immunogenic Induced Pluripotent Stem Cells, a Promising Way Forward for Allogenic Transplantations for Neurological Disorders
    Henriette Reventlow S Frederiksen, Ulrik Doehn, Pernille Tveden‐Nyborg, Kristine Freude · 2021 · Frontiers in Genome Editing
  79. Th17 Cells in Parkinson’s Disease: The Bane of the Midbrain
    Ashley C. Bolte, John R. Lukens · 2018 · Cell stem cell
  80. Neuro-Immunity and Gut Dysbiosis Drive Parkinson’s Disease-Induced Pain
    Katiane Roversi, Natália Callai-Silva, Karine Roversi, May Griffith, Christos Boutopoulos, Rui Daniel Prediger, Sébastien Talbot · 2021 · Frontiers in Immunology
  81. Immunogenetic Determinants of Parkinson’s Disease Etiology
    Pin‐Jui Kung, Inas Elsayed, Paula Reyes‐Pérez, Sara Bandrés‐Ciga · 2022 · Journal of Parkinson s Disease
  82. The Innate and Adaptive Immune Cells in Alzheimer’s and Parkinson’s Diseases
    Boyuan Huang, Yan Zhenxin, Sisi Chen, Zhenhua Tan, Zhitao Zong, Hongbo Zhang, Xiaoxing Xiong · 2022 · Oxidative Medicine and Cellular Longevity
  83. Tyrosinase-induced neuromelanin accumulation triggers rapid dysregulation and degeneration of the mouse locus coeruleus
    Leslie Hassanein, Bernard Mulvey, Harris E. Blankenship, Margaret Tish, Anu Korukonda, L. Cameron Liles, Amanda Lea Sharpe, Jean‐François Paré, Rosa M. Villalba, Xiangchuan Chen et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  84. The therapeutic potential of natural killer cells in neuropathic pain
    Hyoung Woo Kim, Shuaiwei Wang, Alexander J. Davies, Seog Bae Oh · 2023 · Trends in Neurosciences
  85. The role of T-lymphocytes in central nervous system diseases
    Jianing Shen, Ning Bian, Lu Zhao, Jingkuan Wei · 2024 · Brain Research Bulletin
  86. Type 1 narcolepsy: a CD8+ T cell–mediated disease?
    Matilda Degn, Birgitte Rahbek Kornum · 2015 · Annals of the New York Academy of Sciences
  87. Non-Invasive Monitoring of CNS MHC-I Molecules in Ischemic Stroke Mice
    Jing Xia, Ying Zhang, Huanhuan Zhao, Jie Wang, Xueren Gao, Jinpeng Chen, Bo Fu, Yuqing Shen, Fengqin Miao, Jianqiong Zhang et al. · 2017 · Theranostics
  88. Chemiexcitation: Mammalian Photochemistry in the Dark<sup>†</sup>
    Brash, Douglas E., Goncalves, Leticia C. P. · 2023 · Photochemistry and Photobiology
  89. Unaltered T cell responses to common antigens in individuals with Parkinson's disease
    Gregory P. Williams, Kaylin Muskat, April Frazier, Yaqian Xu, José Mateus, Alba Grifoni, Ricardo da Silva Antunes, Daniela Weiskopf, Amy W. Amara, David G. Standaert et al. · 2022 · Journal of the Neurological Sciences
  90. Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
    Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek, Aaushi Pareek, Vivek Kumar Jain, Sonia Sonia, Zeba Farooqui, Ranjeet Kaur, Gurjit Singh · 2024 · Biomolecules
  91. Activation of the immunoproteasome protects SH-SY5Y cells from the toxicity of rotenone
    Congcong Sun, Mingshu Mo, Yun Wang, Wenfei Yu, Chengyuan Song, Xingbang Wang, Si Chen, Yiming Liu · 2019 · NeuroToxicology
  92. Developmental expression and localization of MHC class I molecules in the human central nervous system
    Aifeng Zhang, Hong Yu, Youji He, Yuqing Shen, Ying Zhang, Jiane Liu, Bo Fu, Dan Lv, Fengqin Miao, Jianqiong Zhang · 2015 · Experimental Brain Research
  93. MicroRNAs Modulating Neuroinflammation in Parkinson's disease
    Mohamed Jamal Saadh, Faris Anad Muhammad, Anamika Singh, Mohammed Ahmed Mustafa, Rafil Adnan Hussein Al Zuhairi, Pallavi Ghildiyal, Ghassan Mudher Hashim, Fahad Alsaikhan, Shayan Khalilollah, Reza Akhavan‐Sigari · 2024 · Inflammation
  94. Limbic Encephalitis: Potential Impact of Adaptive Autoimmune Inflammation on Neuronal Circuits of the Amygdala
    Nico Melzer, Thomas Budde, Oliver Stork, Sven Guenther Meuth · 2015 · Frontiers in Neurology
  95. Retrograde interferon‐gamma signaling induces major histocompatibility class I expression in human‐induced pluripotent stem cell‐derived neurons
    Benjamin D. S. Clarkson, Misha S. Patel, Reghann G. LaFrance‐Corey, Charles L. Howe · 2017 · Annals of Clinical and Translational Neurology
  96. Inflammation and heterogeneity in synucleinopathies
    Antoine Freuchet, Anaëlle Pinçon, Alessandro Sette, Cecilia S. Lindestam Arlehamn · 2024 · Frontiers in Immunology
  97. Interdependence of metals and its binding proteins in Parkinson’s disease for diagnosis
    Athira Anirudhan, Prabu Paramasivam, Jaya Sanyal, Tapas Kumar Banerjee, Gautam Guha, Ram Murugesan, Shiek S. S. J. Ahmed · 2021 · npj Parkinson s Disease
  98. A functional role for alpha-synuclein in neuroimmune responses
    Dustin L. Heiden, Brendan Monogue, Muhammad Ali, John David Beckham · 2023 · Journal of Neuroimmunology
  99. Infections in the Etiology of Parkinson’s Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications
    Gabriela Mercado, Christopher Käufer, Franziska Richter, Wouter Peelaerts · 2024 · Journal of Parkinson s Disease
  100. Regulation of MHC Class I Expression in Lung Epithelial Cells during Inflammation
    Justine Mathé, Mohamed Benhammadi, Koichi S. Kobayashi, Sylvie Brochu, Claude Perreault · 2022 · The Journal of Immunology